National Taiwan University Hospital
Taipei, Taiwan
Location status: Recruiting
NCT Number: NCT05689385
The goal of this randomized controlled trial is to compare the effect of eHealth-based cardiac rehabilitation with the effect of usual care on exercise capacity and qualify of life in patients after myocardial infarction.
Interested in participating?
Request Info20 year and older
All sexes
Interventional
Not applicable
Taipei, Taiwan
Location status: Recruiting
Cardiac rehabilitation can improve exercise capacity, life of quality, readmission rate and mortality rate for patients after myocardial infarction. International guidelines list cardiac rehabilitation after myocardial infarction as class IA recommendation. However, low participation rate of cardiac rehabilitation due to barriers such as lacking of time, transport or affordability issues is an unsolved problem worldwide.
eHealth, consisting of telemedicine, mobile health and personalized care using wearable devices has the potential to remove the barriers and become an effective model to deliver cardiac rehabilitation. Thus, we design a randomized controlled trial to compare the effect of a case manager-led eHealth-based cardiac rehabilitation program with usual care on the compliance, physical activity, quality of life, and cardiorespiratory fitness in patients after myocardial infarction.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The 12-wk case manager-led eHCR program includes:
Other names: eHCR
Time frame: at baseline, 12 weeks(post-intervention), and 12 months.
Peak oxygen uptake will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 12 months.
Time frame: at baseline, 12 weeks(post-intervention), and 12 months.
Ventilatory anaerobic threshold will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 12 months.
Time frame: at 12 weeks(post-intervention) and 12 months.
The degree of completion of prescribed exercise will be assessed at 12 weeks and 12 months.
Time frame: at baseline, 12 weeks(post-intervention), and 12 months.
The investigators will assess the change in 36-Item Short Form Survey(SF-36).
Time frame: at baseline, 12 weeks(post-intervention), and 12 months.
The investigators will assess the change in Patient Health Questionnaire (PHQ-9). The PHQ-9 score ranges from 0-27. Higher scores indicate worsen symptoms.
Time frame: at baseline, 12 weeks(post-intervention), and 12 months.
The investigators will assess the change in Generalized Anxiety Disorder scale (GAD-7). The GAD-7 score ranges 0-21. Higher scores indicate worsen symptoms.
Time frame: at baseline, 12 weeks(post-intervention), and 12 months.
The investigators will assess the change in physical activity using Long form International Physical Activity Questionnaire(IPAQ) Taiwan version.
Time frame: at baseline, 12 weeks(post-intervention), and 12 months.
The grip strength will be measured using a grip goniometer with the participants seated and the elbow flexed at 90 degrees.
Time frame: at baseline, 12 weeks(post-intervention), and 12 months.
The isometric knee extension strength will be measured using a dynamometer with participants seated and knee flexed at 90 degrees.
Contact information is provided by the study sponsor or research team.
National Taiwan University Hospital
Other
The Effectiveness of eHealth-based Cardiac Rehabilitation in Post-myocardial Infarction Patients:a Randomized Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07696390
Cardiovascular Diseases, Heart Diseases
Van, Turkey (Türkiye)
View Trial DetailsNCT07362446
AMI, Cardiovascular Diseases
Kingswood, New South Wales, Australia
View Trial DetailsNCT07636642
Acute Coronary Syndrome, Cardiovascular Diseases
Edinburgh, Midlothian, United Kingdom
View Trial DetailsNCT07252856
Cardiovascular Diseases, Heart Diseases
Leuven, Belgium
View Trial Details